Highlights and Quick Summary
- Total current liabilities for the quarter ending June 30, 2022 was $10.2 Million (a -35.39% decrease compared to previous quarter)
- Year-over-year quarterly Total current liabilities decreased by -72.87%
- Annual Total current liabilities for 2021 was $20.7 Million (a -4.17% decrease from previous year)
- Annual Total current liabilities for 2021 was $21.6 Million (a 127.83% increase from previous year)
- Annual Total current liabilities for 2020 was $9.47 Million (a 1.66% increase from previous year)
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total current liabilities of Biofrontera AG Sponsored ADR
Most recent Total current liabilitiesof BFAGY including historical data for past 10 years.Interactive Chart of Total current liabilities of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Total current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | $10.16 | $15.72 | – |
| 2021 | $19.85 | $37.45 | $13.22 | $13.79 | $20.67 |
| 2020 | $10.23 | $10.44 | $8.95 | $10.59 | $9.47 |
| 2019 | – | $13.01 | $18.14 | $8.73 | $12.97 |
| 2018 | – | – | – | $5.52 | $9.18 |
| 2017 | – | – | $4.21 | $3.59 | $4.65 |
| 2016 | $4.91 | – | – | – | $4.91 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic